Comorbid fibromyalgia in migraine patients: clinical significance and impact on daily life

Basit Öğe Kaydı
dc.contributor.authorOnder, Halil
dc.contributor.authorHamamci, Mehmet
dc.contributor.authorAlpua, Murat
dc.contributor.authorUlusoy, Ersin Kasim
dc.date.accessioned2020-06-25T18:34:01Z
dc.date.available2020-06-25T18:34:01Z
dc.date.issued2019
dc.departmentKırıkkale Üniversitesi
dc.descriptionHamamci, Mehmet/0000-0001-7100-3952
dc.description.abstractObjective: Herein, we aimed to investigate the impact of FM in migraine patients and the specific features and discriminations of this group of migraineurs with FM according to patients without FM. Methods: 102 consecutive migraine patients among 18-50 years old who accepted to involve in the study were included. All patients were asked to complete the following self-report questionnaires for the assessment of pain-related disability, migraine-related disability, anxiety, depression, sleep disturbance and quality of life. All statistical analyses were performed using the SPSS statistics 20 program. Results: 92% of the patients were diagnosed with episodic migraine, whereas 8% of them was diagnosed with chronic migraine (CM). Comorbid FM which was detected to present in 30.3% of the patients. FM was more frequent in CM patients and in migraine patients with aura. The analyses comparing FM (+) and FM (-) migraineurs revealed that headache frequency, migraine disease duration, headache impact test, MIDAS scores were significantly higher in FM (+) migraineurs. Furthermore, the vitality and role-emotional domains of the SF-36 resulted in worse scores in the group of FM (+) migraineurs. Conclusion: The results of our study may suggest the presence of FM as a clinical sign of a more severe migraine. However, the long-term prospective studies including these group of patients are needed to understand the prognostic impact and importance of the comorbid FM in migraine.en_US
dc.identifier.citationclosedAccessen_US
dc.identifier.doi10.1080/01616412.2019.1630164
dc.identifier.endpage915en_US
dc.identifier.issn0161-6412
dc.identifier.issn1743-1328
dc.identifier.issue10en_US
dc.identifier.pmid31221031
dc.identifier.scopus2-s2.0-85067901356
dc.identifier.scopusqualityQ3
dc.identifier.startpage909en_US
dc.identifier.urihttps://doi.org/10.1080/01616412.2019.1630164
dc.identifier.urihttps://hdl.handle.net/20.500.12587/7756
dc.identifier.volume41en_US
dc.identifier.wosWOS:000473488300001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofNeurological Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFibromyalgiaen_US
dc.subjectMigraineen_US
dc.subjectComorbidityen_US
dc.subjectAuraen_US
dc.subjectMedication overuse headacheen_US
dc.subjectRelationshipen_US
dc.titleComorbid fibromyalgia in migraine patients: clinical significance and impact on daily lifeen_US
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
Comorbid fibromyalgia in migraine patients clinical significance and impact on daily life.pdf
Boyut:
1.04 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu